A Study Comparing Two Forms of Didanosine in HIV-infected Patients

NCT00002360 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Didanosine

Sponsor

Bristol-Myers Squibb